Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shin Jae Chang"'
Autor:
Pan Kyeom Kim, Sun Ju Keum, Modupe O V Osinubi, Richard Franka, Ji Young Shin, Sang Tae Park, Man Su Kim, Mi Jung Park, Soo Young Lee, William Carson, Lauren Greenberg, Pengcheng Yu, Xiaoyan Tao, Wang Lihua, Qing Tang, Guodong Liang, Madhusdana Shampur, Charles E Rupprecht, Shin Jae Chang
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186380 (2017)
Current post-exposure prophylaxis for rabies virus infection has several limitations in terms of supply, cost, safety, and efficacy. Attempts to replace human or equine rabies immune globulins (HRIG or ERIG) have been made by several companies and in
Externí odkaz:
https://doaj.org/article/369c51fb646f4c058bd13a7d1f12d599
Autor:
Aerin Yoon, Kye Sook Yi, So Young Chang, Sung Hwan Kim, Manki Song, Jung Ah Choi, Melissa Bourgeois, M Jaber Hossain, Li-Mei Chen, Ruben O Donis, Hyori Kim, Yujean Lee, Do Been Hwang, Ji-Young Min, Shin Jae Chang, Junho Chung
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141312 (2015)
To date, four main mechanisms mediating inhibition of influenza infection by anti-hemagglutinin antibodies have been reported. Anti-globular-head-domain antibodies block either influenza virus receptor binding to the host cell or progeny virion relea
Externí odkaz:
https://doaj.org/article/a2125915133e4a2ca98f23d4560fae6f
Autor:
Shin-Jae Chang, Dongjo Kim, Jin Hyoung Kim, Jeong Hun Kim, Kihwang Lee, Dong Hyun Jo, Minseok Chang, Junho Chung, Wonjun Yang, Hyori Kim
Publikováno v:
Oncotarget
Age-related macular degeneration (AMD) is one of the main causes of visual impairment in adults. Visual deterioration is more prominent in neovascular AMD with choroidal neovascularization (CNV). Clinical and postmortem studies suggested that complem
Autor:
Gi-Seong Kwon, Byeong-Pil Lim, Jong Moon Cho, Joon Serk Seo, Shin-Jae Chang, Dong-Il Kim, Yeon Jung Kim, Byung Sub Min
Publikováno v:
Biotechnology Letters. 39:501-509
To evaluate the characteristics of a novel human cell line, F2N78, including growth performance, physicochemical properties, and biological activity via direct comparison with CHO cells. The culture performance and physicochemical properties of antib
Autor:
Jaeseok Yang, Joon Young Jang, Dong Jo Kim, Jae Ghi Lee, Jung Hwa Ryu, Shin Jae Chang, Hyori Kim, Sunjoo Park, Junho Chung, Lori J. West
Publikováno v:
Transplantation. 103(9)
Plasmapheresis in combination with immunoglobulin and rituximab is often used to induce accommodation in ABO-incompatible (ABOi) living-donor transplantation; however, this regimen cannot be applied to cases of ABOi deceased-donor transplantation. He
Autor:
Jun Mo Park, Hee Jeong Jeong, Sun Ah Jeong, Jun-Young Lee, Jung Min Choi, So Jung Lee, Yoon A Park, Shin Jae Chang, Su Yeon Lee, Si Yeon Lee, Yoo Cheol Song, Sung Hwan Kim
Objectives: Therapeutic monoclonal antibody biosimilars are expected to help reduce the sizeable economic burden of targeted treatments. Trastuzumab (Herceptin®), a recombinant humanized monoclonal antibody that binds to the extracellular domain of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d72e6fd6f3adeb31b800560708fcbae
Autor:
Chi Ho Choi, Min Joo Choo, Shin Jae Chang, Jung Yun Kim, Joo Hyuck Lim, Sung Ho Moon, Ju Yeon Kim
Publikováno v:
Journal of the Society of Cosmetic Scientists of Korea. 42:303-309
Autor:
Ki Eun Maeng, Shin-Jae Chang, Young-Bum Kwon, Soo Young Lee, Yae Ji Yang, Jong-Moon Cho, Dong-Il Kim, Keun-Hee Park, Joon Serk Seo, Byung Sub Min
Publikováno v:
Journal of Bioscience and Bioengineering. 121:317-324
A human hybrid cell line, F2N78, was developed by somatic fusion of HEK293 and Namalwa cells for the production recombinant biopharmaceutical proteins. In this study, we performed perfusion culture to verify its potential in culture process used for
Autor:
Ki Jung Lim, Kyoung Hoon Lee, Kyu Dae Kim, Jihun Lee, Hyun Ah Kang, Shin Jae Chang, Jin Soo Bae, Min Joo Choo
Publikováno v:
mAbs
The evaluation of analytical similarity has been a challenging issue for the biosimilar industry because the number of lots for reference and biosimilar products available at the time of development are limited, whilst measurable quality attributes o
Autor:
Soon Kwan Jung, Joon Won Lee, Jae Won Jeon, Kyoung Hoon Lee, Dong-Il Kim, Shin Jae Chang, Jin Soo Bae, Soo Young Lee, Yeon Jung Kim, Byoung Oh Kwon
Publikováno v:
mAbs
Remsima® (infliximab) was recently approved as the world's first biosimilar monoclonal antibody (mAb) in both the European Union and Korea. To achieve this, extensive physicochemical characterization of Remsima® in relation to Remicade® was conduc